DOI: 10.4244/EIJV13SAAA1

Welcome to PCR London Valves 2017

Corrado Tamburino, MD, PhD; Michael Haude, MD, PhD; Stephan Windecker, MD, PhD; Nicolò Piazza, MD, PhD; Bernard Prendergast, MD, FRCP

Welcome to London for the 9th edition of the world’s largest course focused on the rapidly transforming field of transcatheter heart valve therapies. Although we have been discussing transcatheter treatment of valvular heart disease for several years now, building the PCR London Valves agenda is always challenging as many topics need to be clarified and better understood in just a few days together. In other words, we never get bored! As is the tradition at PCR-branded courses, PCR London Valves will offer participants a unique opportunity to attend didactic and interactive sessions while discovering the latest advances in the field.

The EuroIntervention PCR London Valves supplement includes outstanding review articles authored by some of the world’s key opinion leaders in the field and will be not only your companion during the meeting but also a source of knowledge to guide your daily clinical and academic activities back home. This year’s edition includes state-of-the art papers on imaging, transcatheter therapies of aortic, pulmonary, mitral and tricuspid valves, and percutaneous closure of left atrial appendage – these will address some of the burning questions paying particular attention to the knowledge gaps and future direction of these devices. Completing the picture, we provide a large and comprehensive state-of-the-art paper on surgical valve replacement and a visionary article authored by Professor Serruys in the light of recent celebrations to mark the 40th anniversary of the first coronary angioplasty.

As Course Directors of PCR London Valves and on behalf of the entire clinical community, we would like to take the chance to express our profound gratitude to all the colleagues and friends who dedicated their time in sharing their knowledge and experience in this supplement.

Volume 13 Supplement AA
Sep 24, 2017
Volume 13 Supplement AA
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV14SABA1 Sep 7, 2018
Welcome to PCR London Valves 2018: 10th Anniversary Edition
Barbanti M et al
free

10.4244/EIJV9SSA1 Sep 15, 2013
Welcome to PCR London Valves 2013
Thomas M and Windecker S
free

10.4244/EIJV8SQA1 Sep 30, 2012
Welcome to PCR London Valves 2012
Thomas M and Windecker S
free

10.4244/EIJV10I7A136 Nov 20, 2014
PCR London Valves: a very special year
Windecker S et al
free

10.4244/EIJV12SYA1 Sep 18, 2016
Welcome to PCR London Valves 2016: back to the UK
Tamburino C et al
free

10.4244/EIJV10SUA1 Sep 27, 2014
Welcome to PCR London Valves 2014
Thomas M and Windecker S
free

EAPCI Column

Nov 18, 2024
EAPCI at PCR London Valves 2024
free
Trending articles
334.7

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
45.75

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved